Last: | $13.97 |
---|---|
Change Percent: | -1.38% |
Open: | $13.99 |
Close: | $13.97 |
High: | $14.2691 |
Low: | $13.43 |
Volume: | 1,576,884 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$13.97 | $13.99 | $13.97 | $14.2691 | $13.43 | 1,576,884 | 07-26-2024 |
$13.8 | $14.15 | $13.8 | $14.61 | $13.5 | 2,542,913 | 07-25-2024 |
$13.81 | $12.26 | $13.81 | $13.9662 | $11.93 | 3,454,383 | 07-24-2024 |
$12.49 | $11.47 | $12.49 | $12.625 | $11.47 | 2,126,166 | 07-23-2024 |
$11.46 | $11.12 | $11.46 | $11.51 | $10.61 | 2,341,663 | 07-22-2024 |
$11.2 | $11.21 | $11.2 | $11.97 | $11.04 | 2,777,842 | 07-19-2024 |
$11.43 | $12.01 | $11.43 | $12.25 | $11.06 | 3,364,536 | 07-18-2024 |
$12.02 | $12.12 | $12.02 | $12.74 | $11.35 | 3,405,294 | 07-17-2024 |
$12.11 | $11.41 | $12.11 | $12.35 | $11.2 | 2,440,216 | 07-16-2024 |
$11.31 | $11 | $11.31 | $11.74 | $10.69 | 3,525,967 | 07-15-2024 |
$10.65 | $10.03 | $10.65 | $10.95 | $9.82 | 2,795,855 | 07-12-2024 |
$9.89 | $9.5 | $9.89 | $10.24 | $9.13 | 3,803,396 | 07-11-2024 |
$9.3 | $8.87 | $9.3 | $9.3 | $8.56 | 2,125,197 | 07-10-2024 |
$8.72 | $8.15 | $8.72 | $8.86 | $8.0113 | 2,900,074 | 07-09-2024 |
$8.13 | $8.06 | $8.13 | $8.44 | $7.92 | 2,988,451 | 07-08-2024 |
$7.93 | $7.57 | $7.93 | $7.97 | $7.42 | 1,562,547 | 07-05-2024 |
$7.54 | $7.62 | $7.54 | $7.7075 | $7 | 1,712,064 | 07-04-2024 |
$7.54 | $7.62 | $7.54 | $7.7075 | $7 | 1,712,064 | 07-03-2024 |
$7.49 | $7.28 | $7.49 | $8.2875 | $7.24 | 4,673,917 | 07-02-2024 |
$7.06 | $6.83 | $7.06 | $7.195 | $6.69 | 1,954,780 | 07-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...